phase readout
saveNCT06857279: A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
RECRUITINGupdated 11h ago
community read0 votes
Sponsor: Shanghai Henlius Biotech. Phase: PHASE2. Conditions: Carcinoma of Head and/or Neck
view source ↗
comments(0)
5-min edit window · permanent after that